osteocrete
-
Regulatory
Bone Solutions Receives 510(k) Clearance for Expanded Indications of Use for Mg OSTEOCRETE in Intervertebral Body Fusion Procedures
Colleyville, TX., February 13, 2024 — OrthoSpineNews — Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced…
Read More » -
Biologics
Bone Solutions Inc. Successfully Surpasses 1,000 Implanted Cases with OsteoCrete® Magnesium-Based Bone Void Filler
DALLAS, Feb. 25, 2020 /PRNewswire/ — Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, announces it has surpassed 1,000…
Read More » -
Biologics
Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology
COLLEYVILLE, Texas, Aug. 28, 2019 /PRNewswire/ — Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first…
Read More » -
Biologics
WishBone Medical Adds Resorbable Implants to Product Offerings
WARSAW, Ind., Aug. 15, 2019 (GLOBE NEWSWIRE) — WishBone Medical announces a private label distribution agreement with Bone Solutions, Inc.…
Read More » -
Biologics
Bone Solutions Inc. Successfully surpasses 500 implanted cases with OsteoCrete® Magnesium-Based Bone Void Filler
DALLAS, Feb. 26, 2019 /PRNewswire/ — Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, announces it has surpassed 500 cases…
Read More » -
Biologics
Bone Solutions Inc. has successfully completed 250 cases with OsteoCrete® Magnesium-Based Bone Void Filler
DALLAS, Oct. 2, 2018 /PRNewswire/ — Bone Solutions Inc. (BSI), an ortho-biologics technology company announces the first 250 cases of implanted OsteoCrete®. …
Read More » -
Spine
In a First for the Orthopedic Industry, Bone Solutions of Dallas (BSI) Has Received Formal Patent Approval for Its Groundbreaking Magnesium Based Resorbable Bio-Material
Dallas, TX, September 10, 2015 –(PR.com)– Bone Solutions has most recently focused on launching its currently approved FDA extremity/trauma based…
Read More » -
Bone Solutions Inc. (BSI) Prepares Four Additional FDA Filings for OsteoCrete™, Expanding Options for Potential Strategic Partnerships
DALLAS–(BUSINESS WIRE)–Bone Solutions Inc. (“BSI”) announced today that it will soon file four additional 510(k) applications with the FDA related…
Read More »